LIPANTHYL Side Effects

6848637-4 | Colitis Collagenous
on Jul 06, 2010 Male patient from GERMANY , 92 years of age, was treated with Lipanthyl (View Usage). Patient experienced the following unwanted or unexpected effects: colitis collagenous. Lipanthyl dosage: . During the same period patient was treated with SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ).

6780311-5 | Hepatic Failure, Myalgia, Renal Failure Acute, Rhabdomyolysis
Patient was taking Lipanthyl (View Usage). Patient had the following side effects: hepatic failure, myalgia, renal failure acute, rhabdomyolysis on Jun 09, 2010 from GERMANY Additional patient health information: Male patient , 58 years of age, . Lipanthyl dosage: . During the same period patient was treated with PRAVASTATIN (View Pravastatin Review and Pravastatin Label ), CELEBREX (View Celebrex Review and Celebrex Label ), ZOLPIDEM (View Zolpidem Review and Zolpidem Label ), TERCIAN (View Tercian Review and Tercian Label ), TRANXENE (View Tranxene Review and Tranxene Label ), THERALENE (View Theralene Review and Theralene Label ), HALDOL (View Haldol Review and Haldol Label ). Patient was hospitalized.

6736606-4 | Hyperkalaemia, Renal Failure Acute, Rhabdomyolysis
Adverse event was reported on May 12, 2010 by a Female patient taking Lipanthyl (View Usage) (Dosage: ) was diagnosed with dyslipidaemia and. Location: GERMANY , 72 years of age, After Lipanthyl was administered, patient had the following side effects: hyperkalaemia, renal failure acute, rhabdomyolysis. During the same period patient was treated with TAHOR (View Tahor Review and Tahor Label ), INSULINE (View Insuline Review and Insuline Label ), DOLIPRANE (View Doliprane Review and Doliprane Label ), LYRICA (View Lyrica Review and Lyrica Label ), MOPRAL (View Mopral Review and Mopral Label ), DUSPATALIN (View Duspatalin Review and Duspatalin Label ), LERCAN (View Lercan Review and Lercan Label ), FLUDEX (View Fludex Review and Fludex Label ). Patient was hospitalized and became disabled.

6726656-6 | Photosensitivity Reaction
on May 04, 2010 Female patient from GERMANY , 60 years of age, was diagnosed with hypercholesterolaemia and was treated with Lipanthyl (View Usage). Patient experienced the following unwanted or unexpected effects: photosensitivity reaction. Lipanthyl dosage: .


6693734-X | Liver Injury
on Apr 13, 2010 Female patient from GERMANY , 65 years of age, was treated with Lipanthyl (View Usage). Patient had the following side effects: liver injury. Lipanthyl dosage: . During the same period patient was treated with LEVOTHYROX (View Levothyrox Review and Levothyrox Label ).

6693046-4 | Renal Failure
Patient was taking Lipanthyl (View Usage). After Lipanthyl was administered, patient had the following side effects: renal failure on Apr 14, 2010 from FRANCE Additional patient health information: Female patient , 63 years of age, . Lipanthyl dosage: . During the same period patient was treated with GLUCOPHAGE (View Glucophage Review and Glucophage Label ), CELECTOL (View Celectol Review and Celectol Label ), NITRODERM (View Nitroderm Review and Nitroderm Label ), MOTILIUM (View Motilium Review and Motilium Label ), BUSPAR (View Buspar Review and Buspar Label ). Patient was hospitalized.

6681865-X | Renal Failure
Adverse event was reported on Apr 05, 2010 by a Female patient taking Lipanthyl (View Usage) (Dosage: ) . Location: FRANCE , 63 years of age, Patient experienced the following unwanted or unexpected effects: renal failure. During the same period patient was treated with GLUCOPHAGE (View Glucophage Review and Glucophage Label ), CELECTOL (View Celectol Review and Celectol Label ), NITRODERM (View Nitroderm Review and Nitroderm Label ), MOTILIUM (View Motilium Review and Motilium Label ), BUSPAR (View Buspar Review and Buspar Label ).

6674239-9 | Deep Vein Thrombosis, Fall, Phlebitis, Pulmonary Embolism
on Mar 31, 2010 Female patient from GERMANY , 84 years of age, was diagnosed with hypercholesterolaemia, cerebrovascular accident prophylaxis, back pain (What is back pain?) and was treated with Lipanthyl (View Usage). Patient had the following side effects: deep vein thrombosis (What is deep vein thrombosis?), fall (What is fall?), phlebitis, pulmonary embolism (What is pulmonary embolism?). Lipanthyl dosage: . During the same period patient was treated with COUMADIN (View Coumadin Review and Coumadin Label ), LEVOTHYROX (View Levothyrox Review and Levothyrox Label ), PROZAC (View Prozac Review and Prozac Label ), LAMALINE (View Lamaline Review and Lamaline Label ). Patient was hospitalized.

6656674-8 | Deep Vein Thrombosis, Fall, Phlebitis, Pulmonary Embolism
on Mar 24, 2010 Female patient from GERMANY , 84 years of age, was diagnosed with hypercholesterolaemia, cerebrovascular accident prophylaxis, back pain (What is back pain?) and was treated with Lipanthyl (View Usage). After Lipanthyl was administered, patient had the following side effects: deep vein thrombosis (What is deep vein thrombosis?), fall (What is fall?), phlebitis, pulmonary embolism (What is pulmonary embolism?). Lipanthyl dosage: . During the same period patient was treated with COUMADIN (View Coumadin Review and Coumadin Label ), LEVOTHYROX (View Levothyrox Review and Levothyrox Label ), PROZAC (View Prozac Review and Prozac Label ), LAMALINE (View Lamaline Review and Lamaline Label ). Patient was hospitalized.

6649394-7 | Deep Vein Thrombosis, Fall, Phlebitis, Pulmonary Embolism
Patient was taking Lipanthyl (View Usage). Patient experienced the following unwanted or unexpected effects: deep vein thrombosis (What is deep vein thrombosis?), fall (What is fall?), phlebitis, pulmonary embolism (What is pulmonary embolism?) on Mar 17, 2010 from GERMANY Additional patient health information: Female patient , 84 years of age, was diagnosed with hypercholesterolaemia, cerebrovascular accident prophylaxis, back pain (What is back pain?) and. Lipanthyl dosage: . During the same period patient was treated with COUMADIN (View Coumadin Review and Coumadin Label ), LEVOTHYROX (View Levothyrox Review and Levothyrox Label ), PROZAC (View Prozac Review and Prozac Label ), LAMALINE (View Lamaline Review and Lamaline Label ). Patient was hospitalized.

6639651-2 | Deep Vein Thrombosis, Phlebitis, Pulmonary Embolism
Adverse event was reported on Mar 10, 2010 by a Female patient taking Lipanthyl (View Usage) (Dosage: ) was diagnosed with hypercholesterolaemia, cerebrovascular accident prophylaxis, back pain (What is back pain?) and. Location: GERMANY , 84 years of age, Patient had the following side effects: deep vein thrombosis (What is deep vein thrombosis?), phlebitis, pulmonary embolism (What is pulmonary embolism?). During the same period patient was treated with COUMADIN (View Coumadin Review and Coumadin Label ), LEVOTHYROX (View Levothyrox Review and Levothyrox Label ), PROZAC (View Prozac Review and Prozac Label ), LAMALINE (View Lamaline Review and Lamaline Label ). Patient was hospitalized.

6627619-1 | Deep Vein Thrombosis, Phlebitis, Pulmonary Embolism
on Mar 04, 2010 Female patient from GERMANY , 84 years of age, was diagnosed with hypercholesterolaemia, cerebrovascular accident prophylaxis, back pain (What is back pain?) and was treated with Lipanthyl (View Usage). After Lipanthyl was administered, patient had the following side effects: deep vein thrombosis (What is deep vein thrombosis?), phlebitis, pulmonary embolism (What is pulmonary embolism?). Lipanthyl dosage: . During the same period patient was treated with COUMADIN (View Coumadin Review and Coumadin Label ), LEVOTHYROX (View Levothyrox Review and Levothyrox Label ), PROZAC (View Prozac Review and Prozac Label ), LAMALINE (View Lamaline Review and Lamaline Label ). Patient was hospitalized.

6626547-5 | Hyperhomocysteinaemia, Pulmonary Embolism
on Mar 02, 2010 Male patient from GERMANY , weighting 165.3 lb, was diagnosed with hypercholesterolaemia and was treated with Lipanthyl (View Usage). Patient experienced the following unwanted or unexpected effects: hyperhomocysteinaemia, pulmonary embolism (What is pulmonary embolism?). Lipanthyl dosage: . Patient was hospitalized.

6597628-X | Fall, Surgery, Tendon Rupture
Patient was taking Lipanthyl (View Usage). Patient had the following side effects: fall (What is fall?), surgery (What is surgery?), tendon rupture on Feb 13, 2010 from GERMANY Additional patient health information: Male patient , 62 years of age, was diagnosed with coronary arterial stent insertion, blood pressure increased and. Lipanthyl dosage: . During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), BISOPROLOL (View Bisoprolol Review and Bisoprolol Label ). Patient was hospitalized.

6589867-9 | Hyperhomocysteinaemia, Pulmonary Embolism
Adverse event was reported on Feb 10, 2010 by a Male patient taking Lipanthyl (View Usage) (Dosage: ) was diagnosed with hypercholesterolaemia and. Location: GERMANY , weighting 165.3 lb, After Lipanthyl was administered, patient had the following side effects: hyperhomocysteinaemia, pulmonary embolism (What is pulmonary embolism?). Patient was hospitalized.

6577044-7 | Hyperhomocysteinaemia, Pulmonary Embolism
on Feb 02, 2010 Male patient from GERMANY , weighting 165.3 lb, was diagnosed with hypercholesterolaemia and was treated with Lipanthyl (View Usage). Patient experienced the following unwanted or unexpected effects: hyperhomocysteinaemia, pulmonary embolism (What is pulmonary embolism?). Lipanthyl dosage: . Patient was hospitalized.

6552961-2 | Hepatitis Cholestatic
on Jan 14, 2010 Female patient from GERMANY , 50 years of age, was diagnosed with dyslipidaemia, depression (What is depression?), hypertension and was treated with Lipanthyl (View Usage). Patient had the following side effects: hepatitis cholestatic. Lipanthyl dosage: 200 Mg, Unk. During the same period patient was treated with SORTIS (20 Mg, Qd) (View Sortis Review and Sortis Label ), CITALEC (20 Mg, Qd) (View Citalec Review and Citalec Label ), BISOPROLOL FUMARATE (10 Mg, Unk) (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), RAMIPRIL (2.5 Mg, Unk) (View Ramipril Review and Ramipril Label ). Patient was hospitalized.

6546716-2 | Asthenia, Chills, Coombs Positive Haemolytic Anaemia
Patient was taking Lipanthyl (View Usage). After Lipanthyl was administered, patient had the following side effects: asthenia, chills, coombs positive haemolytic anaemia on Jan 13, 2010 from GERMANY Additional patient health information: Female patient , 65 years of age, was diagnosed with influenza immunisation and. Lipanthyl dosage: . During the same period patient was treated with PANDEMRIX (View Pandemrix Review and Pandemrix Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), APROVEL (View Aprovel Review and Aprovel Label ). Patient was hospitalized.

6532319-2 | Abortion Spontaneous
Adverse event was reported on Dec 29, 2009 by a Female patient taking Lipanthyl (View Usage) (Dosage: ) was diagnosed with dyslipidaemia and. Location: GERMANY , 38 years of age, Patient experienced the following unwanted or unexpected effects: abortion spontaneous. Patient was hospitalized and became disabled.

6531266-X | Fall, Surgery, Tendon Rupture
on Dec 31, 2009 Male patient from GERMANY , 62 years of age, was treated with Lipanthyl (View Usage). Patient had the following side effects: fall (What is fall?), surgery (What is surgery?), tendon rupture. Lipanthyl dosage: . During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), BISOPROLOL (View Bisoprolol Review and Bisoprolol Label ). Patient was hospitalized.

6528831-2 | Hyperkalaemia, Renal Failure Acute, Rhabdomyolysis
on Dec 29, 2009 Female patient from GERMANY , 72 years of age, was diagnosed with dyslipidaemia and was treated with Lipanthyl (View Usage). After Lipanthyl was administered, patient had the following side effects: hyperkalaemia, renal failure acute, rhabdomyolysis. Lipanthyl dosage: . During the same period patient was treated with TAHOR (View Tahor Review and Tahor Label ), INSULINE (View Insuline Review and Insuline Label ), DOLIPRANE (View Doliprane Review and Doliprane Label ), LYRICA (View Lyrica Review and Lyrica Label ), MOPRAL (View Mopral Review and Mopral Label ), DUSPATALIN (View Duspatalin Review and Duspatalin Label ), LERCANIDIPINE (View Lercanidipine Review and Lercanidipine Label ), FLUDEX (View Fludex Review and Fludex Label ). Patient was hospitalized and became disabled.

6522672-8 | Fall, Tendon Rupture
Patient was taking Lipanthyl (View Usage). Patient experienced the following unwanted or unexpected effects: fall (What is fall?), tendon rupture on Dec 22, 2009 from GERMANY Additional patient health information: Male patient , 62 years of age, . Lipanthyl dosage: . During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), BISOPROLOL (View Bisoprolol Review and Bisoprolol Label ). Patient was hospitalized.

6478792-X | Agranulocytosis, Asthenia, Chondrocalcinosis, Hyperthermia
Adverse event was reported on Nov 27, 2009 by a Female patient taking Lipanthyl (View Usage) (Dosage: ) was diagnosed with chondrocalcinosis and. Location: GERMANY , 75 years of age, Patient had the following side effects: agranulocytosis, asthenia, chondrocalcinosis, hyperthermia. During the same period patient was treated with COLCHIMAX (View Colchimax Review and Colchimax Label ), LEXOMIL (View Lexomil Review and Lexomil Label ), DAFALGAN (View Dafalgan Review and Dafalgan Label ), SECTRAL (View Sectral Review and Sectral Label ), COVERSYL (View Coversyl Review and Coversyl Label ), FLECAINIDE ACETATE (View Flecainide Acetate Review and Flecainide Acetate Label ), AMLOR (View Amlor Review and Amlor Label ), ASPEGIC 1000 (View Aspegic 1000 Review and Aspegic 1000 Label ). Patient was hospitalized.

6474142-3 | Pulmonary Embolism
on Nov 26, 2009 Female patient from GERMANY , 78 years of age, was diagnosed with hypercholesterolaemia and was treated with Lipanthyl (View Usage). After Lipanthyl was administered, patient had the following side effects: pulmonary embolism (What is pulmonary embolism?). Lipanthyl dosage: . During the same period patient was treated with LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), KARDEGIC (View Kardegic Review and Kardegic Label ). Patient was hospitalized.

6444608-0 | Oedema Peripheral, Polymyositis
on Nov 12, 2009 Male patient from GERMANY , 60 years of age, was diagnosed with hypercholesterolaemia and was treated with Lipanthyl (View Usage). Patient experienced the following unwanted or unexpected effects: oedema peripheral, polymyositis. Lipanthyl dosage: .

6437297-2 | Polymyositis
Patient was taking Lipanthyl (View Usage). Patient had the following side effects: polymyositis on Nov 05, 2009 from GERMANY Additional patient health information: Male patient , 60 years of age, was diagnosed with hypercholesterolaemia and. Lipanthyl dosage: .

6431472-9 | Blood Creatinine Increased, Muscular Weakness, Myalgia, Venous Thrombosis
Adverse event was reported on Oct 29, 2009 by a Female patient taking Lipanthyl (View Usage) (Dosage: ) . Location: POLAND , 78 years of age, After Lipanthyl was administered, patient had the following side effects: blood creatinine increased, muscular weakness, myalgia, venous thrombosis.

6356989-7 | Dry Mouth, Myalgia, Sicca Syndrome
on Sep 11, 2009 Male patient from GERMANY , 76 years of age, was diagnosed with dyslipidaemia and was treated with Lipanthyl (View Usage). Patient experienced the following unwanted or unexpected effects: dry mouth, myalgia, sicca syndrome. Lipanthyl dosage: . During the same period patient was treated with TAHOR (View Tahor Review and Tahor Label ). Patient was hospitalized.

6306740-1 | Hepatic Function Abnormal, Rhabdomyolysis
on Aug 06, 2009 Male patient from GERMANY , 16 years of age, was diagnosed with hypertriglyceridaemia and was treated with Lipanthyl (View Usage). Patient had the following side effects: hepatic function abnormal, rhabdomyolysis. Lipanthyl dosage: . Patient was hospitalized.

6291276-7 | Hepatic Function Abnormal, Rhabdomyolysis
Patient was taking Lipanthyl (View Usage). After Lipanthyl was administered, patient had the following side effects: hepatic function abnormal, rhabdomyolysis on Jul 24, 2009 from GERMANY Additional patient health information: Male patient , 16 years of age, was diagnosed with hypertriglyceridaemia and. Lipanthyl dosage: . Patient was hospitalized.

6272669-0 | Hepatic Function Abnormal, Rhabdomyolysis
Adverse event was reported on Jul 08, 2009 by a Male patient taking Lipanthyl (View Usage) (Dosage: ) was diagnosed with hypertriglyceridaemia and. Location: GERMANY , 16 years of age, Patient experienced the following unwanted or unexpected effects: hepatic function abnormal, rhabdomyolysis. Patient was hospitalized.

6272472-1 | Hepatitis Cholestatic, Jaundice
on Jul 08, 2009 Female patient from GERMANY , 48 years of age, was diagnosed with hypertriglyceridaemia, back pain (What is back pain?), hypothyroidism and was treated with Lipanthyl (View Usage). Patient had the following side effects: hepatitis cholestatic, jaundice (What is jaundice?). Lipanthyl dosage: . During the same period patient was treated with PROPOFAN (View Propofan Review and Propofan Label ), BIPROFENID (View Biprofenid Review and Biprofenid Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), PROPRANOLOL HCL (View Propranolol Hcl Review and Propranolol Hcl Label ), LEVOTHYROX (View Levothyrox Review and Levothyrox Label ), ESBERIVEN (View Esberiven Review and Esberiven Label ), TANAKAN (View Tanakan Review and Tanakan Label ), GAVISCON (View Gaviscon Review and Gaviscon Label ). Patient was hospitalized.

6251313-2 | Hepatic Function Abnormal, Rhabdomyolysis
on Jun 26, 2009 Male patient from GERMANY , 16 years of age, was diagnosed with hypertriglyceridaemia and was treated with Lipanthyl (View Usage). After Lipanthyl was administered, patient had the following side effects: hepatic function abnormal, rhabdomyolysis. Lipanthyl dosage: . Patient was hospitalized.

6192108-8 | Cytolytic Hepatitis, Renal Failure Acute, Rhabdomyolysis
Patient was taking Lipanthyl (View Usage). Patient experienced the following unwanted or unexpected effects: cytolytic hepatitis, renal failure acute, rhabdomyolysis on May 07, 2009 from GERMANY Additional patient health information: Male patient , 49 years of age, . Lipanthyl dosage: . During the same period patient was treated with FORTZAAR (View Fortzaar Review and Fortzaar Label ), LABETALOL HCL (View Labetalol Hcl Review and Labetalol Hcl Label ).

6103979-5 | Myalgia, Renal Failure Acute, Rhabdomyolysis, Transaminases Increased
Adverse event was reported on Feb 26, 2009 by a Male patient taking Lipanthyl (View Usage) (Dosage: ) . Location: GERMANY , 58 years of age, Patient had the following side effects: myalgia, renal failure acute, rhabdomyolysis, transaminases increased. During the same period patient was treated with PRAVASTATIN (View Pravastatin Review and Pravastatin Label ), CELEBREX (View Celebrex Review and Celebrex Label ), DEPAMIDE (View Depamide Review and Depamide Label ), ZOLPIDEM (View Zolpidem Review and Zolpidem Label ), TERCIAN (View Tercian Review and Tercian Label ), TRANXENE (View Tranxene Review and Tranxene Label ), THERALENE (View Theralene Review and Theralene Label ), HALDOL (View Haldol Review and Haldol Label ). Patient was hospitalized.

6097945-6 | Myalgia, Renal Failure Acute, Rhabdomyolysis, Transaminases Increased
on Feb 19, 2009 Male patient from GERMANY , 58 years of age, was treated with Lipanthyl (View Usage). After Lipanthyl was administered, patient had the following side effects: myalgia, renal failure acute, rhabdomyolysis, transaminases increased. Lipanthyl dosage: . During the same period patient was treated with PRAVASTATIN (View Pravastatin Review and Pravastatin Label ), CELEBREX (View Celebrex Review and Celebrex Label ), DEPAMIDE (View Depamide Review and Depamide Label ), ZOLPIDEM (View Zolpidem Review and Zolpidem Label ), TERCIAN (View Tercian Review and Tercian Label ), TRANXENE (View Tranxene Review and Tranxene Label ), THERALENE (View Theralene Review and Theralene Label ), HALDOL (View Haldol Review and Haldol Label ). Patient was hospitalized.

6079090-9 | Thrombosed Varicose Vein
on Feb 06, 2009 Female patient from GERMANY , 72 years of age, was treated with Lipanthyl (View Usage). Patient experienced the following unwanted or unexpected effects: thrombosed varicose vein. Lipanthyl dosage: .

6067023-0 | Thrombosed Varicose Vein
Patient was taking Lipanthyl (View Usage). Patient had the following side effects: thrombosed varicose vein on Jan 29, 2009 from GERMANY Additional patient health information: Female patient , 72 years of age, . Lipanthyl dosage: .

6062677-7 | Cytolytic Hepatitis, Gamma-glutamyltransferase Increased, Transaminases Increased
Adverse event was reported on Jan 26, 2009 by a Male patient taking Lipanthyl (View Usage) (Dosage: ) was diagnosed with hypercholesterolaemia, allergic granulomatous angiitis and. Location: GERMANY , 51 years of age, After Lipanthyl was administered, patient had the following side effects: cytolytic hepatitis, gamma-glutamyltransferase increased, transaminases increased. During the same period patient was treated with IMUREL (View Imurel Review and Imurel Label ). Patient was hospitalized.

6062519-X | Cytolytic Hepatitis
on Jan 26, 2009 Male patient from GERMANY , 51 years of age, was diagnosed with hypercholesterolaemia, allergic granulomatous angiitis and was treated with Lipanthyl (View Usage). Patient experienced the following unwanted or unexpected effects: cytolytic hepatitis. Lipanthyl dosage: . During the same period patient was treated with IMUREL (View Imurel Review and Imurel Label ). Patient was hospitalized.

6045407-4 | Hepatic Steatosis, Hypertriglyceridaemia, Pancreatitis Acute, Type 2 Diabetes Mellitus
on Jan 15, 2009 Male patient from GERMANY , 43 years of age, was diagnosed with hypertriglyceridaemia, schizophrenia and was treated with Lipanthyl (View Usage). Patient had the following side effects: hepatic steatosis, hypertriglyceridaemia, pancreatitis acute, type 2 diabetes mellitus. Lipanthyl dosage: . During the same period patient was treated with ABILIFY (View Abilify Review and Abilify Label ), TERCIAN (View Tercian Review and Tercian Label ), METHADONE HCL (View Methadone Hcl Review and Methadone Hcl Label ), NOVONORM (View Novonorm Review and Novonorm Label ). Patient was hospitalized.

6020541-3 | Liver Injury, Rhabdomyolysis
Patient was taking Lipanthyl (View Usage). After Lipanthyl was administered, patient had the following side effects: liver injury, rhabdomyolysis on Dec 17, 2008 from CHINA Additional patient health information: Female patient , 76 years of age, weighting 131.2 lb, was diagnosed with type 2 diabetes mellitus, hypertension and. Lipanthyl dosage: . During the same period patient was treated with ASPIRIN (Not Reported) (View Aspirin Review and Aspirin Label ), IRBESARTAN (Not Reported) (View Irbesartan Review and Irbesartan Label ), PIPERAZINE FERULAT (Not Reported) (View Piperazine Ferulat Review and Piperazine Ferulat Label ), NOVOLIN N (Not Reported) (View Novolin N Review and Novolin N Label ), METOPROLOL (Not Reported) (View Metoprolol Review and Metoprolol Label ), KETOSTERIL (Not Reported) (View Ketosteril Review and Ketosteril Label ). Patient was hospitalized.

6012506-2 | Hepatic Steatosis, Hypertriglyceridaemia, Pancreatitis Acute
Adverse event was reported on Dec 11, 2008 by a Male patient taking Lipanthyl (View Usage) (Dosage: ) was diagnosed with hypertriglyceridaemia, schizophrenia and. Location: GERMANY , 43 years of age, Patient experienced the following unwanted or unexpected effects: hepatic steatosis, hypertriglyceridaemia, pancreatitis acute. During the same period patient was treated with ARIPIPRAZOLE (View Aripiprazole Review and Aripiprazole Label ), CYAMEMAZINE (View Cyamemazine Review and Cyamemazine Label ), METHADONE HCL (View Methadone Hcl Review and Methadone Hcl Label ), REPAGLINIDE (View Repaglinide Review and Repaglinide Label ). Patient was hospitalized.

5950608-7 | Cytolytic Hepatitis
on Nov 03, 2008 Male patient from GERMANY , 51 years of age, was diagnosed with hypercholesterolaemia, allergic granulomatous angiitis and was treated with Lipanthyl (View Usage). Patient had the following side effects: cytolytic hepatitis. Lipanthyl dosage: . During the same period patient was treated with AZATHIOPRINE (View Azathioprine Review and Azathioprine Label ). Patient was hospitalized.

5939444-5 | Cytolytic Hepatitis, Gamma-glutamyltransferase Increased, Transaminases Increased
on Oct 27, 2008 Male patient from GERMANY , 51 years of age, was diagnosed with hypercholesterolaemia, allergic granulomatous angiitis and was treated with Lipanthyl (View Usage). After Lipanthyl was administered, patient had the following side effects: cytolytic hepatitis, gamma-glutamyltransferase increased, transaminases increased. Lipanthyl dosage: . During the same period patient was treated with AZATHIOPRINE (View Azathioprine Review and Azathioprine Label ). Patient was hospitalized.

5934433-9 | Liver Injury, Rhabdomyolysis
Patient was taking Lipanthyl (View Usage). Patient experienced the following unwanted or unexpected effects: liver injury, rhabdomyolysis on Oct 24, 2008 from CHINA Additional patient health information: Female patient , 76 years of age, weighting 131.2 lb, was diagnosed with type 2 diabetes mellitus, hypertension and. Lipanthyl dosage: . During the same period patient was treated with ACETYLSALICYLIC ACID SRT (Not Reported) (View Acetylsalicylic Acid Srt Review and Acetylsalicylic Acid Srt Label ), IRBESARTAN (Not Reported) (View Irbesartan Review and Irbesartan Label ), PIPERAZINE (Not Reported) (View Piperazine Review and Piperazine Label ), ISOPHANE INSULIN (Not Reported) (View Isophane Insulin Review and Isophane Insulin Label ), METOPROLOL TARTRATE (Not Reported) (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), KETOSTERIL (Not Reported) (View Ketosteril Review and Ketosteril Label ). Patient was hospitalized.

5914371-8 | Dermatosis, Lung Disorder
Adverse event was reported on Oct 02, 2008 by a Male patient taking Lipanthyl (View Usage) (Dosage: ) was diagnosed with hypercholesterolaemia and. Location: GERMANY , weighting 154.3 lb, Patient had the following side effects: dermatosis, lung disorder.

5907503-9 | Dermatosis, Lung Disorder
on Sep 24, 2008 Male patient from GERMANY , weighting 154.3 lb, was diagnosed with hypercholesterolaemia and was treated with Lipanthyl (View Usage). After Lipanthyl was administered, patient had the following side effects: dermatosis, lung disorder. Lipanthyl dosage: .

5902499-8 | Dementia, Haemoptysis, Hypotension, International Normalised Ratio Increased, Overdose
on Sep 24, 2008 Male patient from FRANCE , 82 years of age, was diagnosed with arrhythmia (What is arrhythmia?), atrial fibrillation (What is atrial fibrillation?), type 2 diabetes mellitus and was treated with Lipanthyl (View Usage). Patient experienced the following unwanted or unexpected effects: dementia (What is dementia?), haemoptysis, hypotension, international normalised ratio increased, overdose. Lipanthyl dosage: . During the same period patient was treated with SEROPLEX (View Seroplex Review and Seroplex Label ), ACENOCOUMAROL (View Acenocoumarol Review and Acenocoumarol Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ). Patient was hospitalized.

5893552-6 | Dementia, Haemoptysis, Hypotension, International Normalised Ratio Increased
Patient was taking Lipanthyl (View Usage). Patient had the following side effects: dementia (What is dementia?), haemoptysis, hypotension, international normalised ratio increased on Sep 08, 2008 from FRANCE Additional patient health information: Male patient , 82 years of age, was diagnosed with arrhythmia (What is arrhythmia?), atrial fibrillation (What is atrial fibrillation?), type 2 diabetes mellitus and. Lipanthyl dosage: . During the same period patient was treated with SEROPLEX (View Seroplex Review and Seroplex Label ), ACENOCOUMAROL (View Acenocoumarol Review and Acenocoumarol Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ). Patient was hospitalized.